-
Vernakalant is a new investigational anti-arrhythmic drug. The compound is relatively selective, blocking the early-activating potassium channel and the frequency-dependent sodium channel; it has a half-life of two to three hours.
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
-
Pioglitazone and heart disease; ARBs manufacturers spend millions to show the non-inferiority of their products compared to less expensive, generic ACE inhibitors; some athletes turn to growth hormone because it is difficult to detect; FDA Actions
-
Most of us dread the chief complaint of weakness. This nonspecific symptom engenders a differential that ranges from malingering to fatal, from psychiatric to cancer. The finding of demonstrable muscle weakness helps, but then leads to a confusing set of relatively rare diagnoses.
-
-
Transcranial ultrasound is an inexpensive, non-invasive technique that can be used in early parkinsonism to support clinical diagnosis of Parkinson's disease.
-
Epidural blood patch is an effective treatment for post dural puncture headache.
-
Guillain-Barré syndrome remains a common and serious cause of acute neuropathy in the elderly.
-
In high-risk patients with significant carotid artery stenosis, carotid endarterectomy and carotid stenting appear equivalent both for efficacy and adverse events.
